SMTL ID : 5cxz.1

SYK catalytic domain complexed with naphthyridine inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

monomer

Ligands

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 4 residues within 4Å: Chain A: E.100, L.101, V.151, T.152 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:E.100

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 4 residues within 4Å: Chain A: P.183, V.184, K.185, W.186 Ligand excluded by PLIP

1 x 55U: N-{7-[4-(dimethylamino)phenyl]-1,6-naphthyridin-5-yl}propane-1,3-diamine(Non-covalent)

55U.3: 16 residues within 4Å: Chain A: L.25, V.33, A.48, V.81, M.96, E.97, M.98, A.99, E.100, L.101, G.102, P.103, R.146, N.147, L.149, D.160 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.25, A:L.25, A:A.48, A:V.81, A:L.149 Hydrogen bonds: A:A.99, A:R.146 Water bridges: A:N.147, A:D.160

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Thoma, G. et al., Orally bioavailable Syk inhibitors with activity in a rat PK/PD model. Bioorg.Med.Chem.Lett. (2015)

Release Date

2015-09-16

Peptides

Tyrosine-protein kinase SYK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase SYK

Related Entries With Identical Sequence